DateContentStatus
30/04/2024 Page: Epidemiological data on blood transmissible infections - Scientific guidelineUpdated
29/04/2024 Page: ICH Q3C (R9) Residual solvents - Scientific guidelineUpdated
26/04/2024 Page: Development of a guideline on the safety of nanoparticles – in the context of the establishment of maximum residue limits and veterinary marketing authorisationsNew
26/04/2024 Page: Scientific guidelines for veterinary medicinesUpdated
26/04/2024 Document: Concept paper for the development of a guideline on the safety of nanoparticles – in the context of the establishment of maximum residue limits and veterinary marketing authorisationsNew
18/04/2024 Document: Draft template for assessment report for the development of European herbal monographs and European Union list entries - Revision 6New
18/04/2024 Document: Draft guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin - Revision 1New
12/04/2024 Page: Pharmaceutical quality of inhalation and nasal products - Scientific guidelineUpdated
12/04/2024 Document: Draft guideline on the pharmaceutical quality of inhalation and nasal medicinal productsNew
12/04/2024 Document: Draft guideline on the requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD)New
04/04/2024 Page: Reflection papers on regulatory requirements for the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH) - Scientific guidelineUpdated